This episode of the Atomic Anesthesia Podcast explores the emerging role of Suzetrigine, a novel non-opioid NaV1.8 channel inhibitor, in multimodal surgical pain management. Host Rhea and guest JR Phillips, a DNAP student, discuss the science, efficacy, and safety profile of Suzetrigine, its potential for opioid-sparing strategies, and its unique advantages over traditional opioids and sodium channel blockers. Listen in for an evidence-based look at how this new FDA-approved analgesic could reshape perioperative care, improve patient outcomes, and what its current limitations and future possibilities might be for anesthesia professionals and learners.

To take a quiz about this topic, check out this link: [HERE]

For references for this episode, click [HERE]

Want to learn more? Create a FREE account at www.atomicanesthesia.com

⚛️ CONNECT:

🩷 Subscribe to our YouTube channel

💜 Follow us on Instagram

💙 Follow us on TikTok

📥 Have a topic you want to hear? Email Dr. Temmermand at [email protected]